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Important Rulings Emanating from the Cipollone
Tobacco Trial
ALAN M. DARNELL*
MERYL G. NADLER**
INTRODUCTION
On June 13, 1988, in the Federal District Courthouse in New-
ark, New Jersey, a six person jury found the Liggett Group, Inc.
tobacco company liable for breach of an express warranty made to
Rose Cipollone, and awarded $400,000 to Antonio Cipollone, the
late Rose's husband. The jury's verdict represents the first time
that a plaintiff has won a money damage award against a tobacco
company.1 The money verdict clearly is not the only significant
aspect of the Cipollone case. The case is notorious for having es-
tablished law with regard to discovery protective orders, and with
regard to the doctrine of preemption.' What follows is a discussion
of a series of legal issues that arose during the course of the Ci-
pollone trial, which, although not as well known as such issues as
preemption and discovery protective orders, are nonetheless signif-
icant and worthy of study.
I. THE ADMISSIBILITY UNDER FEDERAL RULE OF EVIDENCE
702 OF TESTIMONY OF DR. JEROME JAFFE, PLAINTIFF'S EXPERT
IN THE FIELD OF HUMAN DEPENDENCE AND ADDICTION
Prior to the beginning of the Cipollone trial in February 1987,
defendants in the case, Liggett Group, Inc., Philip Morris Incor-
porated and Loew's Theaters Incorporated, made a motion for an
in limine hearing to determine, under Federal Rule of Evidence
702,1 the admissibility of the testimony of plaintiff's expert on ad-
* J.D., University of Pennsylvania Law School (1971); named Trial Lawyer of the
year in 1983 and 1988 by Trial Lawyers for Public Justice.
** J.D., University of Pennsylvania Law School (1986).
1. The matter is presently being appealed to the United States Court of Appeals for
the Third Circuit.
2. See Cipollone v. Liggett Group, Inc., 822 F.2d 335 (3d Cir. 1987), cert. denied,
108 S. Ct. 487 (1987); 785 F.2d 1108 (3d Cir. 1986); 789 F.2d 181 (3d Cir. 1986); and
649 F. Supp. 664 (D.N.J. 1986).
3. Federal Rule of Evidence 702 reads:
If scientific, technical, or other specialized knowledge will assist the trier of fact to
understand the evidence or to determine a fact in issue, a witness qualified as an
expert by knowledge, skill, experience, training, or education, may testify thereto
? ???? ?????
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diction, Dr. Jerome Jaffe. Plaintiff had advised defendants by
means of a letter that Dr. Jaffe would testify inter alia:
[T]hat Mrs. Cipollone gives a reasonably typical history of a
heavily dependent smoker who after trying to stop but failing
thereafter avoids making serious efforts but temporizes by
switching to what she felt were safer cigarettes .... To the de-
gree dependence reduces the smoker's capacity to make free and
fully flexible choices, Mrs. Cipollone's capacity to respond in a
fully flexible and free way to the information on risks of smok-
ing provided by the government and other sources of informa-
tion was substantially reduced.
The defendants focused on the final element of Dr Jaffe's opinion
and characterized the evidence as being expert testimony in the
field of "voluntary behavior," in other words, novel scientific evi-
dence. Defendants argued that because Dr. Jaffe's testimony in-
volved novel scientific evidence, under United States v. Downing4
the court was required to conduct a preliminary inquiry focusing
on (1) the soundness and reliability of the process or technique
used in generating evidence; (2) the possibility that admitting the
evidence would overwhelm, confuse, or mislead the jury; and (3)
the proffered connection between the scientific research or test re-
sult to be presented, and particular disputed factual issues in the
case.
5
Plaintiff argued that even if the court were to accept defend-
ants' characterization of Dr. Jaffe's testimony as pertaining to
"voluntary behavior," there was ample precedent allowing psychi-
atrists to testify as to the voluntariness of behavior.6 Plaintiff
maintained that Dr. Jaffe's testimony as an expert in the field of
drug dependence and addiction, and more specifically, tobacco de-
pendence, was not novel scientific evidence at all. In support of
this position, plaintiff presented considerable evidence of clinical
and scholarly studies of the addictive effects of cigarette smoke.
In an opinion rendered October 13, 1987, the Honorable H. Lee
Sarokin held that Dr. Jaffe's testimony concerning tobacco depen-
dence was not "novel" scientific evidence within the meaning of
United States v. Downing,' and therefore, denied defendants' mo-
in the form of an opinion or otherwise.
FED. R. EVID. 702.
4. 753 F.2d 1224 (3d Cir. 1985).
5. Id. at 1237 n.15.
6. United States v. Winters, 729 F.2d 602 (9th Cir. 1984) (in an action for kidnap-
ing and transporting women in interstate commerce for immoral purposes, the court per-
mitted the government to call a psychiatrist as an expert to dispel the notion put forth by
defendant that the victims had voluntary submitted to the conduct by the criminal
defendant).
7. 753 F.2d 1224 (3d Cir. 1985).
[Vol. 25
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tion for an in limine hearing.8 Furthermore, the court held that
based upon the record before it, Dr. Jaffe's proposed expert testi-
mony was helpful to the trier of fact's understanding of the case,
and was therefore admissible under Federal Rule of Evidence
702.1
In so holding, the court rejected defendants' overly generalized
characterization of Dr. Jaffe's opinion as being concerned only
with volition as an abstract concept, ruling instead that Dr. Jaffe's
opinion was based in the more limited field of substance addiction,
or tobacco dependence.' 0 The court was persuaded to rule in
plaintiff's favor in light of the substantial evidence of clinical and
scholarly studies, in both the private and public sectors, of the
addictive effects of cigarette smoke. 1 Moreover, the court recog-
nized that the study of chemical substance addiction and its ef-
fects is a recognized field of medical inquiry.'2 Furthermore, the
court noted that the Surgeon General recognized the addictive po-
tential of cigarette smoke.' 3 In light of the above facts, the court
took judicial notice of the scientific field of the study of chemical
dependence, specifically tobacco dependence. 4
The court rejected defendants' argument that since medical au-
thorities questioned the medical evidence concerning tobacco de-
pendence, the evidence was novel, saying, "disagreement can exist
in an established scientific field; an absence of unanimity over sci-
entific evidence does not make the evidence 'novel.' "1 The court
similarly rejected defendant's argument that the evidence was
novel because Dr. Jaffe's deposition testimony indicated that there
was no empirical scale which had been developed to measure the
extent of this dependence. The court noted that while the absence
of an empirical scale may undermine the validity of Dr. Jaffe's
testimony in the eyes of the jury, it does not, however, indicate
that expert testimony as to tobacco dependence is "novel" scien-
tific evidence.' 6
8. Cipollone v. Liggett Group, Inc., No. 83-2864, slip op. at 6 (D.N.J. Oct. 13,
1987).
9. Id.
10. Id. at 4.
I1. Id.
12. Id.
13. Id. (The 1987 report of the Surgeon General entitled Health Consequences of
Smoking: Nicotine Addiction, which discusses the addictive properties of cigarette smoke
in greater detail than any previous Surgeon General report, was released several months
after the court's ruling on defendants' motion in limine).
14. Id.
15. Id. at 5.
16. Id. at 6. During the course of the trial, defendants' moved to strike the trial
testimony of Dr. Jaffe, arguing that Dr. Jaffe's testimony regarding Mrs. Cipollone's de-
pendence upon cigarettes was insufficient to defeat a defense of contributory negligence,
1989]
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The import of the court's ruling on defendants' motion in limine
is twofold. First, the court legitimized the field of study of tobacco
dependence, and arguably, tobacco litigation. If the trier of fact is
convinced of the addictive qualities of the nicotine in cigarettes, it
is less likely to blame the smoker for continued smoking. Second,
the court further refined the concept of "novel" scientific evidence
and narrowed its scope.
II. THE ADMISSIBILITY UNDER THE FEDERAL RULES OF
EVIDENCE OF TESTIMONY OF DR. JEFFREY HARRIS, PLAINTIFF'S
EXPERT ON STATE-OF-THE-ART IN THE TOBACCO INDUSTRY
In addition to permitting Dr. Jaffe's testimony, the Honorable
H. Lee Sarokin allowed Jeffrey Harris, an M.D., Ph.D., and pro-
fessor at Harvard Medical School, who was qualified as an expert
in the area of scientific knowledge available to the manufacturers
of cigarettes at various points in time, to give his opinion as to
what information a reasonable manufacturer should have known
and should have disclosed to users of its products. The court's de-
cision to allow the testimony of both Dr. Jaffe and Dr. Harris re-
flects the liberal approach to the admissibility of scientific evi-
dence embodied in the Federal Rules of Evidence and the
applicable case law.
One of the issues in the case was whether the defendants had
breached a duty to warn the public, including Rose Cipollone,
about the hazards of cigarettes, prior to 1966, when the govern-
ment required warnings to be placed on cigarette packages. Under
Feldman v. Lederle Labs,17 a manufacturer is held to the standard
of an expert in the field and "should keep abreast of the scientific
advances." 18 Moreover, "in some fields such as those impacting on
public health, a manufacturer may be expected to be informed
and affirmatively to seek out information concerning the public's
assumption of risk, or comparative fault. What defendants attempted to do in their motion
to strike, as well as in their previous motion in limine, was to compare Dr. Jaffe's testimony
regarding Mrs. Cipollone's dependence upon cigarettes and its affect upon her ability to
choose whether or not to smoke to expert testimony proffered and rejected in criminal cases
concerning whether people who are drunk or on drugs can "voluntarily" commit crimes.
See, e.g., United States v. Lyons, 731 F.2d 243 (5th Cir. 1984), cert. denied, 469 U.S. 930
(1984); United States v. Moore, 486 F.2d 1139 (D.C. Cir. 1973), cert. denied, 414 U.S.
980 (1973). The court held that such cases were inapposite in that they were not limited to
an individual's substance addiction in relation to relieving the individual from responsibility
for decisions whether or not to use the particular substance. Cipollone v. Liggett Group
Inc., No. 83-2864, slip. op. at 4 (D.N.J. Oct. 13, 1987). The court held that Dr. Jaffe's
testimony regarding Mrs. Cipollone's ability to choose whether or not to continue smoking
was relevant to whether her smoking was reasonable or voluntary, which issues were impor-
tant to the critical question of causation and to defendants' affirmative defenses. Id.
17. 97 N.J. 429, 479 A.2d 374 (1984).
18. Id. at 453-54, 479 A.2d at 386.
[Vol. 25
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use of its own product."' 9 "Further, a reasonably prudent manu-
facturer will be deemed to know reliable information generally
available or reasonably obtainable in the industry or in the partic-
ular field involved. Such information need not be limited to that
furnished by experts in the field, but may also include material
provided by others."20 Moreover, a manufacturer is under a duty
"whether or not a causal relationship between use of product and
various attendant difficulties has been definitively established at
the time of the warning. '"21 A duty to warn arises when there is
"significant medical evidence of a possible health hazard, without
waiting for a causal relationship to be established by definitive
studies which, in some instances may not be feasible or would take
many years."22
Plaintiff argued that Dr. Harris' opinion as to what research
and testing the tobacco company should have been performing
and as to what information a reasonable manufacturer should
have disseminated to the American public at various points in
time fell within the liberal definition of "helpfulness" contem-
plated in Rule 702.23
After a review of the scientific literature, Dr. Harris formulated
his opinion that the tobacco companies should have researched
and tested cigarettes before 1954, and should have disclosed infor-
mation to the public regarding the health hazards associated with
19. Id. at 453-54, 479 A.2d at 387.
20. Id. (noting customer complaints, articles of preliminary findings by leading re-
searchers in the field, research, and adverse reaction reports).
21. Id. at 454, 479 A.2d at 387 (emphasis added) (citing McKee v. Moore, 648 P.2d
21, 24 (Okla. 1982)).
22. Id. at 453-54, 479 A.2d at 387 (citing Hamilton v. Hardy, 37 Colo. App. 375,
385, 549 P.2d 1099, 1108 (1976); McKee v. Moore, 648 P.2d 21, 24 (Okla. 1982)).
23. See supra notes 3-5 and accompanying text; United States v. Downing, 753 F.2d
1224, 1229 (3d Cir. 1985) (this rule invests trial courts with broad discretion to admit
expert testimony over the objection that it would improperly invade the province of the
jury); S. SALTZBURG & K. REDDEN, FEDERAL RULES OF EVIDENCE MANUAL 451 (3d ed.
1982) (under Rule 702, "an expert can be employed if his testimony will be helpful to the
trier of fact in understanding evidence that is simply difficult, [though] not beyond ordi-
nary understanding"). See also Notes of Advisory Committee on Proposed Rule 702
(Quoting Ladd, Expert Testimony, 5 VAND. L. REv. 414, 418 (1952); 3 J. WEINSTEIN &
M. BERGER, WEINSTEIN'S EVIDENCE § 702, at 702-12 n.6 (citing cases); 7 J. WIGMORE
EVIDENCE § 1923 (3d ed. 1940) ("[T]he only true criterion is: On this subject can a jury
from this person receive appreciable help? In other words, the test is a relative one, de-
pending on the particular witnesses with reference to that subject, and is not fixed or lim-
ited to any class of persons acting professionally.") Cf. Breidor v. Sears, Roebuck & Co.,
722 F.2d 1134, 1138 (3d Cir. 1983) (citing Salem v. United States Lines, 370 U.S. 31, 35
(1962)) (district court invested with broad discretion to admit or exclude expert evidence,
and its action will be sustained unless manifestly erroneous); Knight v. Otis Elevator Co.,
596 F.2d 84, 87 (3d Cir. 1979) (noting the liberal policy of admitting expert testimony
which will "probably aid" the trier of fact) citing Universal Athletic Sales Co. v. American
Gym, Recreational & Athletic Equipment Corp., 546 F.2d 530, 537 (3d Cir. 1976), cert.
denied, 430 U.S. 984 (1977).
1989]
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cigarettes. His opinion was further supported by, and in fact, Dr.
Harris relied on, various internal documents and other testimony.
For example, industry documents revealed:
(1) It was unanimously agreed by the group present that the
tobacco industry has lagged far behind other industries in prod-
uct research.24
(2) The president of Liggett stated in Liggett's 1958 Annual
Report: "My feeling in this business is that there isn't anything
in this tobacco that is carcinogenic that is going to do the indi-
vidual any harm."2
(3) Dr. Mold [Assistant Director of Research at Liggett] testi-
fied in his deposition (i) that he concluded in the late 50s or 60s
that smoking caused lung cancer;26 and (ii) that he wanted to
publish all the information contained in Liggett's submission to
the Surgeon General's Advisory Committee;27
(4) Historically, the joint industry funded smoking and health
research programs have not been selected against specific scien-
tific goals, but rather for various purposes such as public rela-
tions, political relations, and to gain position for litigation.
(5) Thus, it seems obvious that reviews of such programs for
scientific relevance and merit in the smoking and health field are
not likely to produce high ratings.2"
(6) Not more than fifty percent of the AMA/ERF research pro-
gram was relevant to smoking. 9
Plaintiff argued that it was appropriate for Dr. Harris to read
these statements to the jury, all of which were independently ad-
missible in evidence, many of them admissions by defendants, and
to comment about them in relation to his opinion on the complex
subject of scientific knowability.30
24. Record at 1007 (statement made in an internal document found in the files of
Lorillard).
25. Record at 1092.
26. Record at 1195.
27. Record at 1218.
28. Record at 1235-36.
29. Record at 1245.
30. See FED. R. EvID. 703 ("[tjhe facts or data in the particular case upon which an
expert bases his opinion or inference may be those perceived by or made known to the
expert at or before the hearing. If of a type reasonably relied upon by experts in the partic-
ular field in forming opinions or inferences on the subject, the facts or data need not be
admissible in evidence").
There is no doubt that proof of "scientific knowability," i.e., "cutting edge" is a complex
subject. In Beshada v. Johns-Manville Prods. Corp., 90 N.J. 191, 207, 447 A.2d 539, 548
(1982) the Supreme Court of New Jersey stated:
[S]cientific knowability, as we understand it, refers not to what in fact was known
at the time, but to what could have been known at the time. In other words, even
if no scientist had actually formed a belief that asbestos was dangerous, the
hazards would be deemed knowable if a scientist could have formed that belief by
applying research or performing tests that were available at the time. Proof of
what could have been known will inevitably be complicated, costly, confusing and
time-consuming. Each side will have to produce experts in the history of science
[Vol. 25
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Defendants argued that Dr. Harris did not offer assistance to
the jury in evaluating any complex scientific or technical terms.
However, as plaintiff argued, Dr. Harris did not merely interpret
the terms in the documents, rather, as a scientist he interpreted
their meaning in the broader context of the tobacco companies'
responsibility to the public at various points in time. The court
dismissed defendants' argument.
Defendants also attempted to exclude Dr. Harris' testimony re-
garding scientific knowability based upon his review of company
documents and deposition transcripts, on the basis of prejudice.
The defendants cited cases saying that "expert testimony should
be excluded when it assumes a posture of 'mythic infallibility' or
has a false 'aura of reliability.' "31 Defendants once again relied
upon the opinion of United States v. Downing,32 in which the
Third Circuit considered the admission of novel scientific evidence
and set forth a test for determining when scientific evidence was
unduly prejudicial, thus warranting its exclusion.33
The evidence at issue in Downing consisted of the testimony of
a psychologist called by defendant as an expert on the reliability
of eyewitness identification. The Court of Appeals for the Third
Circuit vacated a judgment of conviction entered against the de-
fendant on the basis of the district court's exclusion of the expert's
proffered testimony.34 The Third Circuit Court remanded the case
to the district court for an evidentiary hearing concerning the ad-
missibility of the expert testimony.35 In so ruling, the Third Cir-
cuit Court noted:
The danger that scientific evidence will mislead the jury might
be greater ... where the jury is not presented with the data on
which the expert relies, but must instead accept the expert's as-
sertions as to the accuracy of his conclusions.36
Another factor noted by the court in Downing indicating that sci-
entific evidence is unduly prejudicial is "[t]he extent to which the
and technology to speculate as to what knowledge was feasible in a given year. We
doubt that juries will be capable of even understanding the concept of scientific
knowability, much less be able to resolve such a complex issue. (Emphasis in
original).
31. United States v. Ferri, 778 F.2d 985, 990 (3d Cir. 1985), cert. denied, 476 U.S.
1172 (1986); United States v. Downing, 753 F.2d 1224, 1239 (3d Cir. 1985); see American
Bearing Co. v. Litton Indus., 729 F.2d 943, 949-50 n.14 (3d Cir. 1984), cert. denied, 469
U.S. 854 (1984); New York v. Pullman, Inc., 662 F.2d 910, 915 (2d Cir. 1981), cert.
denied, 454 U.S. 1164 (1982); In re Agent Orange Prod. Liab. Litig., 611 F. Supp. 1223,
1256 (E.D.N.Y 1985).
32. 753 F.2d 1224 (3d Cir. 1985).
33. See supra text accompanying notes 4-5.
34. Downing, 753 F.2d at 1243.
35. Id. at 1244.
36. Id. at 1239.
1989]
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adverse party has had notice of the evidence and an opportunity to
conduct its own tests or produce opposing experts. '37
Plaintiff argued that Dr. Harris' testimony was not unduly prej-
udicial under Downing. Because Dr. Harris read to the jury state-
ments upon which he relied in formulating his opinions, including
numerous scientific studies and articles, the jury could examine
the statements for themselves and was not forced to accept Dr.
Harris' recommendation out of hand. In addition, defendants were
provided with the substance of Dr. Harris' testimony long before
trial and thus, had ample opportunity to produce their own ex-
perts in response to Dr. Harris. Moreover, defendants were able to
cross-examine Dr. Harris at trial and expose any weaknesses in
his testimony. The court clearly agreed with plaintiff, saying:
Dr. Harris was permitted to explain to the jury the facts upon
which his opinions were based. Defendants, on cross-examina-
tion, had the opportunity to question Dr. Harris' use and under-
standing of the documents. Defendants, during their case, may
present witnesses that seek to cast these documents in different
light. Ultimately, as defendants point out, the jury will deter-
mine the significance of the evidence presented. Dr. Harris'
opinions, premised on the documents and depositions may assist
the jury in making its determination. 8
The only restriction the court placed upon Dr. Harris' testimony
was that counsel not ask the witness "whether the defendants
should have warned" or "whether the defendants were under a
duty to warn."' 39 The court did not bar the witness from answering
properly phrased questions by setting forth his recommendations
for the tobacco companies. Defendants nonetheless argued that
when Dr. Harris responded to questions invoking the word
"warn," or by saying that certain information "should have been
disclosed" or that "the public had the right to know" particular
information as part of the recommendations he would have made
to the tobacco companies, Dr. Harris' testimony was tainted be-
cause his responses embraced one of the ultimate issues in the
case, namely whether defendants should have warned the public
of the hazards of smoking prior to 1966.
Plaintiff argued that under our current rules of evidence, specif-
ically Federal Rule of Evidence 704(a), the so-called "ultimate
issue" rule was specifically abolished.4
37. Id. at 1241; see United States v. Bailer, 519 F.2d 463, 466 (4th Cir. 1975).
38. Cipollone v. Liggett Group, Inc., No. 83-2864, slip op. at 3 (D.N.J. May 3,
1988).
39. Record at 957.
40. FED. R. EvID. 704(a) reads: "[T]estimony in the form of an opinion or inference
otherwise admissible is not objectionable because it embraces an ultimate issue to be de-
cided by the trier of fact." In support of his position that this evidence was admissible and
[Vol. 25
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The court, in a brief opinion, held that Dr. Harris' responses to
plaintiff's questions as to what his recommendations to defendants
would have been at various times comported with the court's prior
ruling concerning the prohibition against framing questions in
terms of "duty to warn."41
The Cipollone court's willingness to admit the testimony of Dr.
Jaffe and Dr. Harris reflects the fact that the Federal Rules of
Evidence generally favor admission of evidence of a scientific na-
ture. Whether the two conditions for admissibility of such evi-
dence-a qualified witness who can assist the trier of fact-have
been met, is a preliminary question addressed to the trial court,
which has broad discretion in making these determinations.42
Moreover, under Rule 703, the facts or data upon which an expert
may base his opinion have been expanded to include facts or data
made known to the expert outside of court, in addition to those
perceived by the expert first-hand and those made known to the
expert at trial. Furthermore, with few exceptions, the expert may
render an opinion on an ultimate issue in a case.
not barred by prejudice, plaintiff cited the following cases: United States v. Fogg, 652 F.2d
551 (5th Cir. 1981) (the court allowed an expert accountant called by the government to
testify in a criminal tax evasion case that payments to defendant would be characterized as
"constructive dividends"); United States v. Milton, 555 F.2d 1198, 1204 (5th Cir. 1977)
(in a prosecution for conducting an illegal gambling business, the court affirmed a lower
court's admission of expert testimony although it appeared to be a legal conclusion);
Wetherill v. University of Chicago, 565 F. Supp. 1553 (N.D. I11. 1983) (plaintiffs alleged
injury by exposure in utero to diethystilbestorl (DES), which was administered to their
mothers as part of a university experiment; and the court allowed an expert to testify as to
Illinois' informed consent standard, namely, whether "the reasonable medical practitioner
of the same school, in the same or similar circumstances, would have told the patient of
such [foreseeable] risks" of the challenged treatment); Garrett v. Desa Indus., 705 F.2d
721 (4th Cir. 1983) (the court held that it was reversible error for the trial court to exclude
the opinion testimony of a witness qualified with regard to the design of a particular ma-
chine (in that case, a stud driver) that the design of that machine was "unreasonably dan-
gerous"; the court held that if the witness "is qualified to testify about the stud drivers'
design and manufacture, he may render an opinion as to the ultimate issue in the case").
In each of the two cases cited by defendants in support of the exclusion of expert testi-
mony regarding the so-called ultimate issue, Matthews v. Ashland Chemical, Inc., 770
F.2d 1303 (5th Cir. 1985) and Strong v. E.I. Dupont de Nemours Co., 667 F.2d 682 (8th
Cir. 1981), the question asked of the expert was found by a court to be improper, thus
justifying exclusion of the expert's testimony.
41. Cipollone v. Liggett Group, Inc., No. 83-2864, slip op. at 2 (D.N.J. May 3,
1988).
42. I1 J. MOORE, W. TAGGART & J. WICKER, MOORE'S FEDERAL PRACTICE §
702.10[3] (3d ed. 1985).
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III. JUDGE SAROKIN'S RULING ON DEFENDANT'S MOTION FOR
DIRECTED VERDICT
A. The Design Defect Claim
One of plaintiff's initial causes of action in this matter was a
design defect claim which alleged that defendants failed to market
a safer, alternatively designed cigarette. In support of this cause
of action, plaintiff presented evidence at the trial that such a
safer, alternatively designed cigarette was feasible and available to
defendants as early as 1971, during the period Rose Cipollone
smoked. Dr. Jeffrey Harris, a qualified medical expert, testified
that had defendants marketed the palladium nitrate process ciga-
rette by 1971, when it was feasible to do so, Rose Cipollone's risk
of contracting lung cancer would have been reduced by eight to
seventeen percent. In addition, plaintiff presented the testimony of
Dr. Joel Cohen, an expert in consumer behavior, who testified that
in his opinion, Mrs. Cipollone would have tried the product.
Defendants argued that plaintiff had failed to prove proximate
cause, because plaintiff was required, under the law, to present
evidence that the alternative design more likely than not would
have prevented plaintiff's injury.4 a Plaintiff argued that, under the
"lost chance" doctrine,44 he was only required to present evidence
that defendant's conduct increased plaintiff's risk of contracting
lung cancer and that such increased risk was a "substantial fac-
tor" producing plaintiff's condition.45
The court was thus faced with the task of determining the ap-
propriate test for measuring causation on the design defect claim.
The court's task was complicated by the fact that no New Jersey
court had expressly ruled on the applicability of the "lost chance"
doctrine to product liability cases, and thus, the court had to pre-
dict how the New Jersey Supreme Court would decide this ques-
tion.46 The court predicted that the New Jersey Supreme Court
would not apply the "lost chance" doctrine to this case.41
In so holding, the court noted that the test of proximate cause
in strict product liability actions is generally whether a defend-
43. See, e.g., Brown v. United States Stove Co., 98 N.J. 155, 174, 484 A.2d 1234,
1244 (1984).
44. The theory behind the "lost chance" doctrine is that a plaintiff can recover for
damage suffered as a result of another actor's nonfeasance that reduced the probability of
avoiding an injury actually sustained. See Cipollone v. Liggett Group, Inc., 683 F. Supp.
1487, 1494 (D.N.J. 1988); Herber v. Johns-Manville Corp., 785 F.2d 79, 82-83 (3d Cir.
1986).
45. See, e.g., Evers v. Dollinger, 95 N.J. 399, 417, 471 A.2d 405, 414-15 (1984).
46. Cipollone v. Liggett Group, Inc, 683 F. Supp. 1487, 1493 (D.N.J. 1988); See
also Hon v. Stroh Brewery, 835 F.2d 510, 512 (3d Cir. 1987).
47. Cipollone, 683 F. Supp. at 1493-94.
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ant's conduct was a substantial factor in bringing about an acci-
dent that caused a plaintiff's injury. 8 The court also noted that in
Brown v. United States Stove Co.,49 a design defect case, the New
Jersey Supreme Court ruled that a plaintiff had failed to present a
jury question on proximate cause in the absence of evidence that
the alternative design would "realistically or likely . . . have pre-
vented the kind of injury" incurred by plaintiff." The court recog-
nized that the "lost chance" doctrine had been applied by the
New Jersey Supreme Court in the medical malpractice context in
Evers v. Dollinger,51 wherein it was held that a physician who
failed to diagnose cancer could be held liable if it was demon-
strated that the physician's conduct increased plaintiff's risk and
that this increased risk was a substantial factor in producing
plaintiff's condition. 2
The court also took note that the New Jersey Supreme Court
applied Evers to a claim for failure to rescue in Hake v.
Manchester Township,53 wherein the court held that given defend-
ant's breach of a duty to assist plaintiff, plaintiff was only re-
quired to show that there was "a substantial possibility" that
plaintiff might have been rescued if defendant had acted prop-
erly.5 4 While the court acknowledged that the rationale of the
"lost chance" doctrine could extend to product liability claims
based upon a failure to act, the court was quick to note that the
New Jersey courts had failed to apply the "lost chance" rule in
product liability cases arising after Evers55 and Hake.56 Thus, the
court was unwilling to invoke this doctrine, which would have
eased the burden of establishing proximate cause by not requiring
plaintiff to produce definitive proof that had defendant acted by
developing the safer alternative cigarette, Mrs. Cipollone's injuries
would have been prevented.57
What likely motivated the court to find that the New Jersey
Supreme Court would not adopt the "lost chance" doctrine in this
48. Id. at 1494 (citing Malin v. Union Carbide, 219 N.J. Super. 428, 439, 530 A.2d
794, 799 (1987); Hull v. Getty Ref. & Mktg. Co., 202 N.J. Super. 461, 467, 495 A.2d
445, 449 (App. Div. 1985)).
49. 98 N.J. 155, 484 A.2d 1234 (1984).
50. Id. at 174, 484 A.2d at 1244; see Cipollone, 683 F. Supp. at 1494.
51. 95 N.J. 399, 471 A.2d 405 (1984).
52. Id. at 417, 471 A.2d at 415; see Cipollone, 683 F. Supp. at 1494.
53. 98 N.J. 302, 486 A.2d 836 (1985).
54. Cipollone, 683 F. Supp. at 1494; id. at 311, 486 A.2d at 841.
55. See, e.g., Brown v. United States Stove Co., 98 N.J. 155, 484 A.2d 1234; Cam-
pos v. Firestone Tire & Rubber Co., 98 N.J. 198, 485 A.2d 305 (1984).
56. See, e.g., Malin v. Union Carbide, 219 N.J. Super. 428, 530 A.2d 794 (1987);
Hull v. Getty Ref. & Mktg. Co., 202 N.J. Super. 461, 467, 495 A.2d 445 (App. Div.
1985). Cipollone, 683 F. Supp. at 1494.
57. Cipollone, 683 F. Supp. at 1495.
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products liability case was the fact that the New Jersey Legisla-
ture had recently passed a products liability act, a provision of
which states that a manufacturer may not be held liable for a
design defect if there did not exist a feasible alternative design
"that would have prevented the harm. ' 58 In a footnote, the court
noted that although it was not holding that the provision of this
statute applied retroactively to this case, it expressed the view that
the New Jersey Supreme Court would be unlikely to modify the
standards set forth in Brown"9 and Campos"° for pending cases
not covered by this statute.'
The significance of the court's decision with respect to plaintiff's
alternative design claim is that it substantially increases a plain-
tiff's burden to prove such a claim by requiring, in essence, that a
plaintiff prove the impossible: prevention of an injury which actu-
ally occurred, as a result of the marketing of an alternative prod-
uct which, in reality, defendants failed to do.
B. The Intentional Wrongdoing Claim
Another significant aspect of the court's decision regarding de-
fendants' motion for a directed verdict was its finding that plain-
tiff had presented sufficient evidence from which the jury could
conclude that defendants intentionally misled the public and/or
deprived the public of information necessary to make informed
choices about the hazards of smoking, and that defendants con-
spired to misrepresent and conceal facts regarding the dangers of
smoking.2 The court stated:
The evidence presented also permits the jury to find a tobacco
industry conspiracy, vast in scope, devious in its purpose and
devastating in its results. The jury may reasonably conclude that
defendants were members of and engaged in that conspiracy
with full knowledge and disregard for the illness and death it
would cause, and that Mrs. Cipollone was merely one of its
58. N.J. STAT. ANN § 2A:58C-3(a)(1) (West 1987).
59. Brown v. United States Stove Co., 98 N.J. 155, 484 A.2d 1234 (1984).
60. Campos v. Firestone Tire & Rubber Co., 98 N.J. 198, 485 A.2d 305 (1984).
61. Cipollone, 683 F. Supp. at 1495 n.7.
62. Id. at 1490-93, 1500. Count 8 of plaintiff's complaint provides, in pertinent part,
that:
Defendants were or should have been at all times relevant hereto, in possession of
medical and scientific data which indicated that the use of its cigarettes was haz-
ardous to the health of consumers, but prompted by pecuniary motives, the de-
fendants, Liggett Group, Inc., Philip Morris Incorporated and Loew's Theatres,
Inc. individually and as members of the tobacco industry ignored and failed to act
upon said medical and scientific data and conspired to deprive the public, and
particularly the consumer of the defendants' products, of said medical and scien-
tific data.
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victims.6 3
In so holding, the court rejected defendants' argument that
plaintiff's claims, premised on suppression of information held by
third parties, were preempted by the Federal Cigarette Labeling
and Advertising Act. 4 The court also rejected defendants' argu-
ment that Mrs. Cipollone's continued smoking after the appear-
ance of the congressionally-mandated warnings in 1966 relieved
defendants of liability as a matter of law. 5 As was pointed out by
plaintiff in his brief, the New Jersey courts have held that where a
defendant is guilty of reckless or wanton misconduct, the rule that
contributory conduct (or comparative negligence) is a bar to re-
covery does not apply. 6
In addition, the court agreed with plaintiff that he would be
entitled to recover punitive damages, assuming that he made the
requisite showing of "intentional wrongdoing in the sense of an
'evil minded act' or an act accompanied by a wanton and wilful
disregard of the rights of another."67 Most significantly, the court
stated: "If the jury accepts the plaintiff's version of the facts as to
the conduct of the defendants, it is difficult to envision a more
compelling case for an award of punitive damages. 68 It appears
that the judge's opinion would favor future plaintiffs' tobacco
cases. The question then arises, why, if the judge found that there
was sufficient evidence for the jury to find the existence of a con-
spiracy in the case, did the jury find that defendants were not lia-
ble for conspiracy? Without delving into the minds of the jurors,
it may have been the case that the jurors also found a conspiracy
to exist, however, they may not have found the defendant's acts to
be a proximate cause of Rose Cipollone's injuries, 69 which was re-
quired in order to find defendants liable on this cause of action.
Perhaps, in another case involving a plaintiff with a different
smoking history, a jury will find defendant tobacco companies lia-
ble for a conspiracy.
63. Id. at 1493.
64. Id. at 1499-1500 n.19; See also Cipollone v. Liggett Group, Inc., 649 F. Supp.
664, 674 (D.N.J. 1986).
65. Cipollone, 683 F. Supp. at 1500.
66. See Entwistle v. Draves, 102 N.J. 559, 510 A.2d 1 (1986) and Borelli v. Frollani,
92 N.J. Super. 203, 207, 236 A.2d 613, 616 (App. Div. 1967).
67. Cipollone, 683 F. Supp. at 1500.
68. Id. (emphasis added).
69. The jury found that Mrs. Cipollone was 80% responsible for her smoking
behavior.
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IV. PLAINTIFF'S UNREASONABLY UNSAFE PRODUCT RISK-
UTILITY CLAIMS
On October 27, 1987, the Honorable H. Lee Sarokin granted
defendants' motion for judgment on the pleadings and dismissed
plaintiff's unreasonably unsafe product risk-utility claims, on the
basis that New Jersey's recently enacted Section 3(a)(2) of the
Product Liability Act"0 was applicable to the case and barred
plaintiff's claims as a matter of New Jersey law.7 1 Section 3(a)(2)
of the Act provides that a manufacturer may not be held liable on
a design defect claim if.
The characteristics of the product are known to the ordinary
consumer or user, and the harm is caused by an unsafe aspect of
the product that is an inherent characteristic of the product and
70. 1987 N.J. Sess. Law Serv. 188-93 (Vol. 6 1987).
71. Cipollone v. Liggett Group, Inc., No. 83-2864 slip op. at 5-6 (D.N.J. Oct. 27,
1987).
According to the New Jersey courts, seven factors are relevant to the determination of
whether a product's utility outweighs its risk:
(1) The usefulness and desirability of the product-its utility to the user and to
the public as a whole.
(2) The safety aspects of the product-the likelihood that it will cause injury,
and the probable seriousness of the injury.
(3) The availability of a substitute product that would meet the same need and
not be as unsafe.
(4) The manufacturer's ability to eliminate the unsafe character of the product
without impairing its usefulness or making it too expensive to maintain its utility.
(5) The user's ability to avoid danger by the exercise of care in the use of the
product.
(6) The user's anticipated awareness of the dangers inherent in the product and
their avoidability, because of general public knowledge of the obvious condition of
the product, or of the existence of suitable warnings or instructions.
(7) The feasibility, on the part of the manufacture, of spreading the loss by
setting the price of the product or carrying liability insurance.
Cepeda v. Cumberland Eng'g Co., 76 N.J. 152, 174, 386 A.2d 816, 826-27 (1978)
(quoting Wade, On the Nature of Strict Tort Liability for Products, 44 MIss. L.J. 825,
837-38 (1973)); See also Cipollone v. Liggett Group, Inc., 644 F. Supp. 283, 290 (D.N.J.
1986), in which the court held that defendants were prohibited under New Jersey law from
introducing evidence as to collateral social benefits of cigarette production stating: "[ilt is
the benefit and utility to the cigarette smoker which is here in issue, and not the benefit to
the cigarette industry or those in turn who benefit from its existence."
In Cipollone, the plaintiff argued that cigarettes are so dangerous and of such little
utility that under the above-described risk-utility analysis, the court should find cigarettes
to be defective and impose liability on the manufacturer. See Note, The Smoldering Issue
in Cipollone v. Liggett Group, Inc: Process Concerns in Determining Whether Cigarettes
are a Defectively Designed Product, 73 CORNELL L. REv. 606, 607 (1988). Cipollone v.
Liggett Group, Inc, 644 F. Supp. 283, 286 (D.N.J. 1986). In general, a court engaged in a
risk-utility analysis determines whether a product is defective by comparing the utility of
the product with the risk of injury it poses to the public. Note, supra, at 607. In most cases
of design defect, the plaintiff produces evidence of a technologically feasible, alternative
design with which the court can compare the particular design at issue. Id. at 607. How-
ever, in O'Brien v. Muskin Corp., 94 N.J. 169, 463 A.2d 298 (1983), the New Jersey
Supreme Court held that in the absence of an alternative design, a jury may find a product
defective if that product's usefulness is outweighed by its dangers. Note, supra, at 608-09.
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that would be recognized by the ordinary person who uses or
consumes the product with the ordinary knowledge common to
the class of persons for whom the product is intended.
If Section 3(a)(2) was found to have incorporated Restatement
(Second) of Torts, section 402(A), comment (i) into New Jersey
law, it would bar plaintiff's risk-utility claim. The issue faced by
the court was whether the New Jersey Legislature intended this
provision to apply to cases filed prior to the enactment of the Act.
Section 8 of the Act addresses this question.
This Act shall take effect immediately except that provisions of
this Act that establish new rules with respect to the burden of
proof or the imposition of liability in product liability actions
shall apply only to product liability actions filed on or after the
date of enactment. 2
Under this provision, Section (3)(a)(2) would apply to this case,
unless it established a new rule with respect to the imposition of
liability in product liability actions.73 What persuaded the court to
find that Section (3)(a) was a provision codifying existing law was
a New Jersey Assembly Insurance Committee Statement on this
bill which addressed the Legislature's intent on this question:
Section 8 provides that the act shall take effect immediately,
except that provisions of the act that establish new rules with
respect to the burden of proof or the imposition of liability in
product liability actions shall apply only to actions filed on or
after the date of enactment. This provision is appropriate be-
cause certain provisions of the act simply codify the existing
common law of the State, which should continue to apply in
pending cases as well as new cases. For example ... the New
Jersey courts have adopted certain provisions of the commentary
to the American Law Institute's Restatement (Second) of Torts,
(e.g., comments i and k to section 402A) that are codified in this
act.... Certain other provisions of the act .... however, estab-
lish new rules for products liability actions .... It is intended
that such new rules apply to cases filed on or after the date of
enactment. "
The court further noted that in connection with section 3(a)(2),
the legislative history states, "the 'consumer expectations' test has
been recognized by New Jersey courts."75 Thus, the court held
that in passing the aforementioned Act, the New Jersey Legisla-
72. 1987 N.J. Sess. Law Serv. 188-193 (Vol. 6 1987).
73. Cipollone v. Liggett Group, Inc., No. 83-2864, slip op. at 3 (D.N.J. Oct. 27,
1987).
74. Id. at 3-4 (D.N.J. Oct. 27, 1987) (citing Assembly Insurance Committee State-
ment, at 708). Section 1(a) of the Act contains the legislative finding that "committee
statements that may be adopted or included in the legislative history of this act shall be
consulted in the interpretation and construction of this act." Id. at 4.
75. Id. at 4.
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ture considered Section 3(a)(2) as a codification of existing com-
mon law, and therefore intended that this section apply to pending
cases.
76
Plaintiff thereafter filed a petition for rehearing of the issue of
the applicability of the risk-utility test, in which he argued that
the court had given undue weight to reports or statements by leg-
islative committees in resolving whether Section 3(a)(2) repre-
sented preexisting New Jersey law or new law. Specifically, plain-
tiff argued that the provision of the Act said merely that the
legislative history be consulted in the interpretation and construc-
tion of the Act but did not operate to incorporate the committee
statements as part of the Act; nor to mandate the court's concur-
rence in such statements.
Plaintiff called the court's attention to O'Brien v. Muskin
Corp.;77 Suter v. San Angelo Foundary & Machine Co.;78 and
Cepeda v. Cumberland Engineering Co.79 Although the New
Jersey Supreme Court referred to "consumer expectations" in
each of these cases, the "consumer expectations" test is quite dif-
ferent from the test referred to in these cases. These cases used
the "consumer expectations" as a floor to manufacturer liability,
rather than a ceiling. In other words, if a product does not per-
form as a consumer expected it to perform, then the manufacturer
of the product would be liable. This is far different from the use of
the phrase "consumer expectations" in comment (i) to Section
402A, which says that if a product conforms to a consumer's ex-
pectations with regard to the product's performance, then a manu-
facturer is relieved of liability with respect to the product. Thus,
the latter use of the term "consumer expectations" refers to a
quasi-assumption of the risk test, i.e., if the consumer is aware of
certain hazards associated with a product, then a manufacturer
cannot be found liable.
Plaintiff argued that if the court had exercised its undoubted
right to limit the weight it attributed to the statements of the leg-
islative committees to that which the statements deserved on their
merits, the court would not have concluded that it was the intent
of the New Jersey Legislature in adopting Section 8 of the Act to
hold that Section 3(a)(2) was a codification of preexisting law,
and not the promulgation of a new rule as to products liability in
New Jersey. Plaintiff maintained that in each of the above cases,
76. Id. at 5. The court noted its disagreement with the legislature's interpretation of
New Jersey common law, however, it held that it could not ignore the legislature's inten-
tions in passing the Act. Id.
77. 94 N.J. 169, 463 A.2d 298 (1983).
78. 81 N.J. 150, 406 A.2d 140 (1979).
79. 76 N.J. 152, 386 A.2d 816 (1978).
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the "consumer expectations" test was used as an evidentiary crite-
rion for liability rather than for immunity, unlike the provision
under discussion in Section 3(a)(2) of the Product Liability Act. 0
Plaintiff was also quick to point out that Judge Sarokin himself in
a previous opinion rendered in this case,"' recognized the proper
place in the law of New Jersey of the "consumer expectations"
test:
According to the New Jersey Supreme Court's most recent pre-
cedent in this regard, however, compliance with consumer ex-
pectations is simply not the only-nor even the most impor-
tant-factor to consider when determining whether a
manufacturer should be found liable for placing any product on
the market. Although consumer's expectations are relevant to
the overall determination of whether a product's risks outweigh
its utility, a product that complies with those expectations, may,
nonetheless, lead to strict liability if other considerations (for ex-
ample, the "usefulness and desirability of the product" as bal-
anced against "the likelihood that it would cause injury, and the
probable seriousness of the injury") indicate that the manufac-
turer acted unreasonably in placing the product on the market.82
The court refused to reconsider its position with regard to the
appropriate design defect test and plaintiff's petition for rehearing
was denied. Thus, plaintiff was prevented from presenting evi-
dence at trial pertaining to his risk-utility claims. 83
80. The declared understanding by the Cepeda court as to the meaning of Comment
(i) of Section 402(A) is merely that a normally useful product will not be regarded as
defective where the harm in its use is solely because of improper or excessive use or adul-
teration. Id. at 170, 386 A.2d at 824-25. This is a completely different concept from the
declaration in Section 3(a)(2) of the new Act that there is no liability for a product whose
characteristics are known to the ordinary consumer, and the harm is caused by an unsafe
aspect of the product that is an inherent characteristic of it, which would be recognized by
the ordinary person who uses or consumes it. In Suter, the court stated that where it is
"self-evident that the product is not reasonably suitable and safe and fails to perform,
contrary to the user's reasonable expectation that it would 'safely do the jobs for which it
was built' . . . the manufacturer's responsibility would be clear without more." It is thus
apparent that the attention of the court in Suter, insofar as reasonable expectations of the
purchaser are concerned, was to circumstances which would inculpate the defendant as a
matter of law, not those which would exculpate him. The mere assertion of the former
proposition by the court does not necessarily imply adoption of a principle of immunity as a
matter of law where the harm is not beyond the consumer's expectations. The allusion to a
"consumer expectations" test in the decision of O'Brien has no broader significance than
that which was just explained in regard to the Suter opinion, which the O'Brien court cites
as authority for its statement:
Another standard is the consumer expectations test, which recognizes that the fail-
ure of the product to perform safely may be viewed as a violation of the reasona-
ble expectation of the consumer.
O'Brien, 94 N.J. at 182, 463 A.2d at 304.
81. Cipollone, 649 F. Supp 664, 670 n.2 (D.N.J. 1986).
82. Id. (citing O'Brien, 94 N.J. at 182-83, 463 A.2d at 304.
83. Significantly, on October 19, 1988, the New Jersey Supreme Court granted a
plaintiff's motion for leave to appeal a recent appellate division decision concerning the
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When it came time to charge the jury in this case, plaintiff ar-
gued once again that the court should not charge the jury that a
manufacturer has a duty to warn only if those dangers are beyond
that which would be contemplated by the ordinary consumer be-
cause this version of the "consumer expectations" test had been
rejected by the New Jersey courts. The court nonetheless charged
the jury:
In considering whether Liggett was under a duty to warn, you
should consider the extent to which ordinary consumers prior to
1966 were aware that cigarette smoking posed significant health
risks. You need not consider whether consumers knew of partic-
ular diseases that could be caused-only whether consumers
were aware that the product posed significant health risks. The
obviousness of a product's danger-as measured by such general
consumer knowledge, not by a particular plaintiff's knowl-
edge-is one element to be considered in order for you to deter-
mine whether a duty to warn exists. However a manufacturer is
not automatically relieved of its duty to warn merely because
the danger is patent-known or apparent.
Plaintiff argued that the court should exercise its own judgment
in deciding what weight, if any, to give to legislative statements
regarding the state of preexisting common law, especially where
the court itself found that the Assembly Committee's description
of that preexisting law was wrong. The effect of the court's ruling
on risk-utility was substantial in that it deprived plaintiff of a
powerful cause of action when applied to a product such as ciga-
rettes, which arguably have little utility, but which cause much
damage. From a plaintiff's perspective, it is hoped that the New
Jersey Supreme Court will exercise its judgment in reviewing the
appellate division's decision in Dewey v. R.J. Reynolds."4
impact of the new Products Liability Act in another tobacco case. See Dewey v. Brown &
Williamson Tobacco Corp., No. A-3227-86-TS, A-3229-86-TS, slip op. (App. Div. 1988).
84. Id.
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